3rd International Symposium on Biology, Prevention, and Treatment of Toxicities After Transplantation and Cellular Therapy - On Demand

Monday, May 15, 2023, 9:00 AM - Wednesday, January 31, 2024, 1:00 PM

This 3rd international Symposium brings together a diverse group of experts and thought leaders in the fields of HCT, cellular therapies, and related medical subspecialties. Speakers discuss current advances in the field, mechanisms of toxicities, symptom burden, and late effects after HCT and cellular therapies along with best practices to prevent and treat these complications.

This unique program includes sessions dedicated to a wide range of pre-clinical, translational, and clinical topics, including cellular therapies as a model of accelerated aging, CAR T cell-related toxicities, infectious complications, decision science, the role of the gut microbiome in toxicities, debates on how to diagnose and treat difficult complications such as transplant-associated thrombotic microangiopathy, and several keynote lectures from leading experts.

View the brochure from the 2023 live Symposium for a complete list of PDFs and select recorded lectures.

Target Audience

The target audience for this Symposium includes physicians, advanced practice providers (physician assistants and nurse practitioners), and nurses who treat or refer patients for hematopoietic cell transplantation or immune effector cell therapies (i.e., CAR T cells; tumor infiltrating lymphocytes, or T cell receptor therapy).

On Demand Content and Access

This on demand contains 20+ recorded lectures and panel discussions along with PDF versions of the speakers' slides. Select the 'Register' tab at the top of this page to purchase this on demand Symposium. Once you have successfully registered, access to the course materials will be available under the 'Course Content' tab.

1. Identify the mechanisms of the most common treatment-related toxicities after HCT and cellular therapy.
2. Discuss the best practices in the prevention and treatment of toxicities and symptom burden after HCT and cellular therapy.
3. Collaborate with a multidisciplinary group of colleagues to discuss, brainstorm, and plan future quality improvement and research efforts to reduce toxicities, improve the patient experience, and decrease non-relapse mortality.

On Demand Fees

• Physicians (MDs, PhDs, PharmDs, and DOs): $450
• Advanced Practice Providers: $350
• Residents, Fellows, Nurses, Data Managers, and Other Healthcare Providers: $275
• MSK Employees: Complimentary

A registration discount is available for MSK Alumni and MSK Cancer Alliance members. If you are a member of one of these groups, please contact [email protected] for details. After your payment has been processed, no further promotional discounts or adjustments will be made to your registration.

This MSK CME on demand program is non-refundable.

Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement

Memorial Sloan Kettering Cancer Center designates this enduring material for a maximum of 12.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

Recorded/Review Date: April 28-29, 2023; Original Release Date: May 15, 2023; Termination Date: January 31, 2024

MSK Symposium Director

Sergio A. Giralt, MD
Deputy Division Head; Attending, Division of Hematologic Malignancies
Melvin Berlin Family Chair in Multiple Myeloma
Chief Medical Officer, MSK Direct
Bone Marrow Transplant and Cellular Therapy Services 
Department of Medicine  

 

MSK Symposium Co-Director

Michael Scordo, MD
Assistant Attending
Bone Marrow Transplant and Cellular Therapy Services 
Department of Medicine  


Symposium Planning Committee

Rafael F. Duarte, MD, PhD, FRCP
Head, Department of Hematology and Transplantation Programme, 
Hospital Universitario Puerta de Hierro Majadahonda;
Profesor Asociado de Hematología - Universidad Autónoma de Madrid
Madrid, Spain

Shahinaz Gadalla, MD, PhD
Senior Investigator, Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics 
National Cancer Institute, NIH
Bethesda, MD 

Vincent T. Ho, MD 
Clinical Director, Adult Hematopoeitic Stem Cell Transplantation 
Dana-Farber Cancer Institute
Boston, MA

Shernan Holtan, MD
Associate Professor of Medicine 
University of Minnesota 
Minneapolis, MN

Robert R. Jenq, MD
Associate Professor, Deputy Chair, Genomic Medicine
University of Texas MD Anderson Cancer Center 
Houston, TX

Karthik Nath, MBBS, PhD
Assistant Attending , Cellular Therapy Service
Memorial Sloan Kettering Cancer Center 
New York, NY 

Armin Rashidi, MD, PhD
Associate Professor
Fred Hutchinson Cancer Center 
Seattle, WA

Gabriela Rondon, MD
Professor, Department of Stem Cell Transplantation - Research, Division of Cancer Medicine
University of Texas MD Anderson Cancer Center 
Houston, TX

Melody Smith, MD, MS
Assistant Professor, Medicine 
Division of Blood and Marrow Transplantation and Cellular Therapy 
Stanford Medicine 
Stanford, CA

Anthony D. Sung, MD
Associate Professor of Medicine
Duke Blood Cancer Center 
Durham, NC

Anna Sureda, MD, PhD
Head of Department, Clinical Hematology Department
Institut Català d’Oncologia - Hospitalet
Barcelona, Spain

 

John Reid Wingard, MD 
Deputy Director, University of Florida Health Cancer Center
Director, Bone Marrow Transplant Program 
UF Health Cancer Center 
Gainesville, FL

William A. Wood, MD, MPH
Professor of Medicine
University of North Carolina School of Medicine 
Chapel Hill, NC

Gregory A. Yanik, MD
Professor, Pediatric Hematology/Oncology, Pediatrics, and Internal Medicine,
Medical Director, Bone Marrow, Medical School
University of Michigan Medicine 
Ann Arbor, MI

 

MSK Symposium Faculty 

Genovefa Papanicolaou, MD
Attending Physician
Infectious Disease Service 
Professor, Weill Cornell Medicine

Jonathan Peled, MD, PhD
Assistant Attending
Bone Marrow Transplant and Cellular Therapy Service

Jacob Glass, MD, PhD
Assistant Attending
Leukemia Service

Gunjan L. Shah, MD, MS
Assistant Attending
Bone Marrow Transplant and Cellular Therapy Service

 

Invited Symposium Faculty 

Lawrence A. David, MD, PhD  
Associate Professor, Molecular Genetics and Microbiology 
Duke University School of Medicine
Durham, NC 

Mette Hazenberg, MD, PhD
Cinical Hematologist; Physician-Scientist; Group Leader, Immunologist
Amsterdam UMC and Sanquin Research
Amsterdam, The Netherlands 

Josh Hill, MD
Associate Professor, Vaccine and Infectious Disease and Clinical Research 
Fred Hutchinson Cancer Center
Seattle, WA

Shernan Holtan, MD
Associate Professor of Medicine 
University of Minnesota
Minneapolis, MN 

Jonathan Huggins, MD
Assistant Professor, Medicine and Infectious Diseases 
Duke University School of Medicine
Durham, NC

Nandita Khera, MD, MPH
Professor, Medicine
Mayo Clinic Alix School of Medicine 
Phoenix, AZ

Marcela Maus, MD
Associate Professor, Medicine
Harvard Medical School 
Massachusetts General Hospital Cancer Center
Boston, MA

Laura Niedernhofer, MD, PhD
Director, Institute on the Biology of Aging and Metabolism
The University of Minnesota
Minneapolis, MN

Amanda Olson, MD
Associate Professor
Department of Stem Cell Tranplantation and Cellular Therapy
MD Anderson Cancer Center
Houston, TX

Samir Parekh, MD
Professor of Medicine
Mount Sinai
New York, NY

Daniel Richardson, MD
Assistant Professor
The University of North Carolina
School of Medicine
Chapel Hill, NC 

Mary Mansour Riwes, DO
Assistant Professor
Department of Internal Medicine
Division of Hematology and Oncology 
University of Michigan, Rogel Cancer Center
Ann Arbor, MI

Prof. Johannes Schetelig, MD, MSc
Head DKMS Clinical Trials Unit
Head Stem Cell Transplantation Unit
University Hospital Carl Gustav Carus
Technical University Dresden 
Dresden, Germany

Nirali N. Shah, MD, MHSc
Head, Hematologic Malignancies Section
National Cancer Institute, NIH 
Bethesda, MD

Noha Sharafeldin, MD, MSc, PhD
Assistant Professor
Division of Hematology & Oncology 
Institute for Cancer Outcomes and Survivorship 
The University of Alabama at Birmingham
Birmingham, AL

Robert Soiffer, MD
Chief, Division of Hematologic Malignancies 
Dana-Farber Cancer Institute
Boston, MA

Marion Subklewe, MD
Attending Physician
Head of Immunotherapy in Hematology
LMU University Hospital Munich
Munich, Germany

 

Relevant Financial Relationships

Mitigation of Relevant Financial Relationships

Memorial Sloan Kettering Cancer Center adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers, or others are required to disclose all financial relationships with ineligible companies (commercial interests). All relevant financial relationships have been mitigated prior to the commencement of the activity.